Charles Schwab Investment Management Inc Bluebird Bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 553,060 shares of BLUE stock, worth $4.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
553,060
Previous 554,183
0.2%
Holding current value
$4.7 Million
Previous $543,000
47.15%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding BLUE
# of Institutions
150Shares Held
63.4MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$131 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$89 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$39.8 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$39.7 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$32.7 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $656M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...